COMPASS PATHWAYS PLC Public Float
COMPASS PATHWAYS PLC (CMPS) had Public Float of $257.10 million as of 2025-06-30, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-24
- 2025-06-30: Entity Public Float $257.10M.
- 2024-06-30: Entity Public Float $354.80M.
- 2023-06-30: Entity Public Float $215.70M.
- 2022-06-30: Entity Public Float $247.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $257.10M 10-K · filed 2026-03-24 |
| 2024-06-30 | $354.80M 10-K · filed 2025-02-27 |
| 2023-06-30 | $215.70M 10-K · filed 2024-02-29 |
| 2022-06-30 | $247.20M 10-K · filed 2023-02-28 |
| 2021-06-30 | $825.00M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |